Asahi Kasei Life Science expects to offer the bioindustry more agile and focused services and deeper innovation in bioprocess ...

The immediate reaction to the Colossal Biosciences’ claims from a broad section of the scientific community was highly ...

The infant was conceived using a workstation that uses AI and robotics to automate the steps required for in vitro ...

Immediate use for the newly developed assembloids could include studying neurodevelopmental disorders such as autism.

Researchers have identified mutated proteins strongly linked to bone cancer by constructing a multimodal map of human ...

GEN editors discuss Colossal's dire wolves, the impacts of tariffs on biotech, and the sweeping government layoffs and leadership departures.

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

Spatial biology first entered the omics scene about a decade ago. Since then, the technology has generated significant buzz ...

Results of the Phase III HERCULES trial suggest the first potential treatment option for a form of multiple sclerosis.

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and ...

President Donald Trump’s exemption of pharmaceuticals from “reciprocal” tariffs limited the declines of biopharma stocks as ...